Search Medical Condition
Please enter condition
Please choose location

Inflammatory Bowel Disease Clinical Trials

A listing of Inflammatory Bowel Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (181) clinical trials

Local doctors are looking for people with Ulcerative Colitis for clinical research studies of an investigational medication. Must be receiving treatment for Ulcerative Colitis Must be at least 18 years old Ulcerative Colitis must be present for at least 3 months prior to first visit

Phase N/A

Children with inflammatory bowel disease are asked to participate in a research study being conducted by Schneider Children’s Hospital. You may be eligible to participate in this study if you: Are a minor 17 years or younger Have been diagnosed with inflammatory bowel disease for at least 2 months You ...

Phase N/A

Winthrop University Hospital’s Clinical Trials Center is seeking volunteers with moderately to severely active Ulcerative Colitis. The main purpose of this study is to see if an investigational medication is useful and safe for treating patients with moderately to severely active ulcerative colitis. Eligible participants will receive study-related medication and ...

Phase

A research study is evaluating a nutritional intervention for Crohn’s Disease.

Phase N/A

Wake Research Associates is looking for volunteers for a research study of an investigational drug for moderate to severe Crohn’s disease. The study will test the drug’s safety and effectiveness.

Phase

The purpose of this study is to compare the efficacy of ferric maltol and intravenous iron (IVI) Ferric Carboxy Maltose in the treatment of iron deficiency anaemia (IDA) and subsequent maintenance of haemoglobin in subjects with Inflammatory Bowel Disease (IBD).

Phase

The purpose of this study is to assess the effect of vedolizumab in the subcutaneous form.

Phase

To assess the effect of vedolizumab SC maintenance treatment on clinical remission at Week 52 in subjects with moderately to severely active UC who achieved clinical response at Week 6 following administration of vedolizumab IV at Weeks 0 and 2.

Phase

A study to evaluate the safety and efficacy of an investigational drug in subjects with moderate to severe Crohn's disease. REF: 001-CGI

Phase

A phase 3 research study of an oral investigational medication as induction and maintenance therapy for adults ages 18 to 75 with moderate to severe ulcerative colitis. Note, study participants may receive the investigational medication or placebo. For more information, please visit our study website at: www.TrueNorthStudy.com

Phase